SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis -- Ignore unavailable to you. Want to Upgrade?


To: Keiko who wrote (1425)3/11/1998 4:50:00 PM
From: jad  Respond to of 1693
 
Quidel Corp. (QDEL) 3 7/16 -1/8: developer and marketer of rapid immunodiagnostic products is warning that Q4 operating net to come in below expectations due to higher expenses and delays in shipments; according to First Call, QDEL was projected to earn $0.09 a share, vs year-ago net of $0.06 a share on revenues of $12.91 mln; in Q3, QDEL earned $0.07 a share on revenues of $13.44 mln..... from Briefing.

Dead Money becoming more DEAD!



To: Keiko who wrote (1425)3/12/1998 2:51:00 PM
From: David B.  Read Replies (1) | Respond to of 1693
 
Yeah, Keiko, QDEL should try to consolidate the industry. A merger or buyout of some of the smaller players (e.g. TRIBY) is what I'm hoping for. Revenue growth--either through new products or takeovers should be their immediate goal.